Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Country / region: Denmark Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20103
20122
20171
20181
20201
20211
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erling Bjerregaard Pedersen2
Regional Hospital Holstebro2
Akcea Therapeutics1
Amgen1
Asger Lund, MD1
Celladon Corporation1
Herlev and Gentofte Hospital1
Jan Frystyk1
KAI Pharmaceuticals1
Silence Therapeutics plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases15
Heart Diseases6
Kidney Diseases4
Atherosclerosis3
Inflammation3
Coronary Artery Disease2
Dyslipidemias2
Hyperlipidemias2
Hypertension2
Hypertrophy, Left Ventricular2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.